New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
March 3, 2015
10:32 EDTMCDMcDonald's volatility increases on sharp one-week rally
Subscribe for More Information
07:59 EDTMCDMcDonald's price target raised to $112 from $101 at BofA/Merrill
Subscribe for More Information
07:39 EDTMCDExecutives' Club of Chicago to hold a breakfast meeting
Maria Green, SVP, General Counsel and Secretary, at Illinois Tool Works, Julia Howe, U.S. Franchising & former General Counsel at McDonald's China participate in a a Breakfast Discussion entitled, "Understanding Top Legal Challenges for Today’s Executive" is being held in Chicago on March 3 at 8:15 am.
06:43 EDTMPELMacau reports February casino revenue down 48.6% to 19.54B patacas
Subscribe for More Information
March 2, 2015
16:02 EDTMCDOptions Update; March 2, 2015
iPath S&P 500 VIX Short-Term Futures down 91c to 26.70. Option volume leaders: AAPL TSLA TWTR MBI MCD NFLX AMZN GOOG BAC C according to Track Data.
09:34 EDTMCDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL MNTA CELG TSLA MCD ARUN GILD KO TWTR NFLX
07:08 EDTTSMCiti says channel checks negative for Altera, Intel, Xilinx
Citigroup says its channel checks indicate Altera's (ALTR) 14nm tapeout at Intel (INTC) has been pushed out again from Q2 to the second half of the year. Its checks also show that Altera has been "very aggressive" in pricing to gain back market share in Asia. Citi sees the two issues as negative for Altera, Intel and Xilinx (XLNX), and positive for TSMC (TSM) and Samsung.
06:51 EDTMCDMcDonald's CEO to discuss tournaround plans this week, WSJ says
Subscribe for More Information
February 27, 2015
09:35 EDTMCDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL MCD GOOG MNST BAC TSLA NFLX SINA AMZN WYNN
February 26, 2015
16:00 EDTMCDOptions Update; February 26, 2015
iPath S&P 500 VIX Short-Term Futures down 33c to 27.78. Option volume leaders: AAPL TSLA TWTR C ZNGA MCD RIG NFLX according to Track Data.
09:35 EDTMCDActive equity options trading on open
Subscribe for More Information
08:29 EDTMPELDeutsche cuts 2015 Macau growth forecast to down 21.4%
Deutsche Bank lowered its 2015 Macau gross gaming revenue forecast to down 21.4% from down 8.4% saying the demand issues will not be solved by expanding capacity. The firm's confidence in a Macau turnaround remains "muted," but it continues to view shares of MGM Resorts (MGM) as "meaningfully undervalued." It views Buy-rated Wynn Resorts (WYNN) as better suited for longer term investors at this stage, and lowered its price target for the stock to $170 from $176. Deutsche also cut its price target for Hold-rated Las Vegas Sands (LVS) to $49 from $53.
February 25, 2015
16:00 EDTMCDOptions Update; February 25, 2015
Subscribe for More Information
11:41 EDTMCDTrade unions say McDonald's avoided over $1B of taxes in Europe
Subscribe for More Information
10:01 EDTMPELOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:30 EDTMPELMelco Crown downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
07:18 EDTRHHBYG Corp to hold annual meeting
Subscribe for More Information
06:14 EDTRHHBYPTC Therapeutics takeout price likely tops $100/share, said Credit Suisse
Credit Suisse yesterday raised its price target for PTC Therapeutics (PTCT) shares to $100 from $66 after Reuters reported the drug market is starting a sale process with Shire (SHPG) and Biomarin (BMRN) as possible suitors. The firm believes a takeout is a likely outcome before or after data the Phase III data expected to be announced in October. PTC has Translarna Phase III trials ongoing in Duchenne muscular dystrophy and cystic fibrosis to support full approval in the U.S. Credit Suisse said yesterday in a note to investors that a takeout value for the company likely exceeds $100 per share. It believes PTC would be a good fit for Vertex (VRTX), Biogen (BIIB), Roche (RHHBY) and others. The firm kept an Outperform rating on the stock. PTC Therapeutics shares closed yesterday up $6.20 to $71.16.
February 24, 2015
13:23 EDTAETAetna, Virtua Medical Group expand relationship
Subscribe for More Information
09:52 EDTMPELMacau to review mainland’s individual visit scheme, Macau Business Daily says
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use